LGVN Insider Trading

Insider Ownership Percentage: 19.12%
Insider Buying (Last 12 Months): $370,049.60
Insider Selling (Last 12 Months): $0.00

Longeveron Insider Trading History Chart

This chart shows the insider buying and selling history at Longeveron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Longeveron Share Price & Price History

Current Price: $2.20
Price Change: +0.30 (1.20%)
As of 11/8/2024 01:00 AM ET

This chart shows the closing price history over time for LGVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Longeveron Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/11/2024Mohamed Wa'el Ahmed HashadCEOBuy10,638$2.35$24,999.3019,616View SEC Filing Icon  
4/11/2024Rock SofferDirectorBuy31,915$2.35$75,000.25208,534View SEC Filing Icon  
4/10/2024Joshua HareInsiderBuy106,383$2.35$250,000.05590,727View SEC Filing Icon  
1/10/2024Cathy RossDirectorBuy500$13.10$6,550.001,000View SEC Filing Icon  
12/28/2023Jeffrey PfefferDirectorBuy1,000$13.50$13,500.001,500View SEC Filing Icon  
6/29/2023James ClavijoCFOSell500$35.10$17,550.004,730View SEC Filing Icon  
6/27/2023James ClavijoCFOSell853$34.80$29,684.406,230View SEC Filing Icon  
1/27/2023Joshua HareInsiderSell2,000$42.80$85,600.00779,326View SEC Filing Icon  
12/2/2022Joshua HareInsiderSell2,000$37.40$74,800.00781,326View SEC Filing Icon  
10/12/2022Joshua HareInsiderSell10,000$36.10$361,000.00781,326View SEC Filing Icon  
6/3/2022James ClavijoCFOSell3,695$82.60$305,207.007,961View SEC Filing Icon  
5/23/2022Rock SofferDirectorSell800$77.80$62,240.0067,635View SEC Filing Icon  
5/20/2022Rock SofferDirectorSell750$80.60$60,450.0068,435View SEC Filing Icon  
4/18/2022Joshua HareInsiderSell1,992$100.00$199,200.00791,334View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Longeveron (NASDAQ:LGVN)

10.01% of Longeveron stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LGVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Longeveron Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024Renaissance Technologies LLC146,700$0.24M0.0%N/A2.311%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,836,000$2.50M0.0%N/A7.312%Search for SEC Filing on Google Icon
7/21/2023Creative Planning109,322$0.37M0.0%N/A0.519%Search for SEC Filing on Google Icon
5/13/2022Sassicaia Capital Advisers LLC102,004$1.41M7.0%N/A0.488%Search for SEC Filing on Google Icon
5/12/2022Anson Funds Management LP20,000$0.28M0.0%N/A0.096%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.22,124$0.27M0.0%N/A0.112%Search for SEC Filing on Google Icon
11/16/2021TownSquare Capital LLC14,450$51K0.0%N/A0.076%Search for SEC Filing on Google Icon
11/3/2021TAP Consulting LLC10,000$35K0.0%N/A0.052%Search for SEC Filing on Google Icon
10/13/2021Private Capital Group LLC12,000$42K0.0%+140.0%0.063%Search for SEC Filing on Google Icon
8/16/2021Matrix Asset Advisors Inc. NY35,000$0.29M0.0%+16.7%0.184%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC38,200$0.31M0.0%N/A0.201%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC14,788$0.12M0.0%N/A0.078%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.131,260$1.07M0.0%+811.5%0.691%Search for SEC Filing on Google Icon
5/13/2021Matrix Asset Advisors Inc. NY30,000$0.20M0.0%N/A0.158%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Longeveron logo
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Read More on Longeveron

Today's Range

Now: $2.20
Low: $2.15
High: $2.24

50 Day Range

MA: $2.03
Low: $1.78
High: $2.25

52 Week Range

Now: $2.20
Low: $0.77
High: $23.90

Volume

280,751 shs

Average Volume

692,482 shs

Market Capitalization

$31.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Longeveron?

Longeveron's top insider shareholders include:
  1. Joshua Hare (Insider)
  2. Rock Soffer (Director)
  3. Mohamed Wa'el Ahmed Hashad (CEO)
  4. James Clavijo (CFO)
  5. Jeffrey Pfeffer (Director)
  6. Cathy Ross (Director)
Learn More about top insider investors at Longeveron.